瑞基海洋生物科技股份有限公司 Approved
最後更新時間 2025/05/02 , 01:55 AM
最後更新時間 2025/05/02 , 01:55 AM
負責人
Liu,Zheng-Zhong
統一編號
27489806
成立日期
2004/11/12
資本額
NT$1,500,000,000
實收資本額
NT$574,574,690
股票代號
4171
電話
04-24639869
地址
No. 19, Keyuan 2nd Rd., Xitun Dist., Taichung City, 407, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Liu,Zheng-Zhong Chairman 4.02%
Vacancy Director 0.00% ZHONG SHI INVESTMENT LTD.
Zhong,De-Yu Director 0.03%
Liu,Cong-Han Director 0.00%
Luo,Zhu-Fang Independent Director 0.00%
Cai,Jia-Jun Independent Director 0.00%
Ye,Yao-Sheng Independent Director 0.00%
營業項目
  • Manufacture of Medicinal Biological Products(200300)
  • Manufacture of Other Chemical Products Not Elsewhere Classified(199012)
  • Manufacture of Medicinal Chemical Products(200599)
  • Manufacture of Measuring, Navigating and Control Equipment(275114)
  • 公司歷程
  • Change Capital to 1,500,000,000
    2024/06/25
  • Change Capital to 600,000,000
    2012/03/16
  • 員工人數
    財務報表
    項目 2024 2023 2022
    Operating income 206,488 225,460 750,017
    Operating cost 88,211 197,876 259,947
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 118,277 27,584 490,070
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 118,277 27,584 490,070
    Operating expenses 249,492 256,869 248,727
    Other gain (loss), net - - -
    Operating profit (loss) -131,215 -229,285 241,343
    Non-operating income and expenses 14,238 10,940 31,028
    Net profit (loss) before tax -116,977 -218,345 272,371
    Income tax expense (benefits) 6,703 -47,993 54,884
    Net profit (loss) of ongoing business for the current period -123,680 -170,352 217,487
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -123,680 -170,352 217,487
    Other comprehensive profit (loss), net 2,726 -938 6,054
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -120,954 -171,290 223,541
    Net profit (loss) attributable to owners of parent company -118,734 -166,270 221,337
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests -4,946 -4,082 -3,850
    Comprehensive profit (loss) attributable to owners of parent company -115,082 -166,653 226,793
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests -5,872 -4,637 -3,252
    Basic earnings per share (yuan) -2 -2 4
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities -23,224 -38,673 357,633
    Net cash inflows (outflows) from investing activities -70,210 -249,912 -48,011
    Net cash inflow (outflow) from financing activities 3,433 -215,885 -228,283
    Effect of Exchange Rate Changes on Cash and Cash Equivalents -16,502 -27,372 3,841
    Increase (decrease) in cash and cash equivalents in the current period -106,503 -531,842 85,180
    Beginning balance of cash and cash equivalents 216,772 748,614 663,434
    Ending balance of cash and cash equivalents 110,269 216,772 748,614
    項目 2024 2023 2022
    Current asset 594,669 632,139 1,070,075
    Non-current asset 471,819 544,003 551,826
    Total asset 1,066,488 1,176,142 1,621,901
    Current liability 239,528 205,904 385,086
    Non-current liability 101,469 107,802 134,140
    Total liability 340,997 313,706 519,226
    share capital 574,575 574,575 459,660
    Equity - secruity token - - -
    capital reserve 144,896 144,896 144,896
    retained earning -3,285 114,740 464,436
    Other equity 794 -2,149 -1,328
    Treasury stock - - -
    Total equity attributable to owners of parent company 716,980 832,062 1,067,664
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 8,511 30,374 35,011
    Total Equity 725,491 862,436 1,102,675
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 12 14 23
    動產抵押
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    存款不足之退票事宜
    時間 金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • SATLite
  • 瑞基
  • POCKIT
  • IQ REAL
  • POCKIT設計字
  • 胃清
  • GENEREACH及GR設計圖
  • 和去病
  • cubee
  • GeneReach
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Others
    2017
  • Pay salary
    2017
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。